Kinins

Kidney International (1981) 19, 869–880; doi:10.1038/ki.1981.91

Renal kallikrein-kinin: Its relation to renal prostaglandins and renin-angiotensin-aldosterone in man

Keishi Abe1, Makito Sato1, Yutaka Imai1, Toshiaki Haruyama1, Ko Sato1, Masao Hiwatari1, Yutaka Kasai1 and Kaoru Yoshinaga1

1Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan

Correspondence: Dr K Abe, Department of Internal Medicine, Tohoku University School of Medicine, 1-1 Seiryocho, Sendai 980, Japan

Received 11 December 1980.

Top

References

  1. Abe K: Urinary excretion of kinin in man with special reference to its origin. Tohoku J Exp Med 87:175–184, 1965
  2. Nustad K: Localization of kininogenase in the rat kidney. Br J Pharmacol 39:87–98, 1970
  3. Carretero OA, Scicli AG: Renal kallikrein: its localization and possible role in renal function. Fed Proc 35:194–198, 1976 | PubMed | ISI | ChemPort |
  4. Ørstavik TB, Nustad K, Brandtzaeg P, Pierce JV: Cellular origin of urinary kallikrein. J Histoehem Cytochem 24:1037–1039, 1976
  5. Larsson C, Änggård E: Regional differences in the formation and metabolism of prostaglandins in the rabbit kidney. Eur J Pharmacol 21:30–36, 1973 | PubMed |
  6. Lee JB, Covino BG, Takman BH, Smith ER: Renomedullary vasodepressor substance, medullin: Isolation, chemical characterization and physiological properties. Circ Res 17:57–77, 1965 | PubMed | ISI | ChemPort |
  7. Ferreria SH, Vane JR: Prostaglandins: Their disappearance from and release into the circulation. Nature 216:868–873, 1967 | Article |
  8. Larsson C, Änggård E: Mass spectrometric determination of prostaglandin E2, F2alpha, and A2 in the cortex and medulla of the rabbit kidney. J Pharm Pharmacol 28:326–328, 1976
  9. Frölich JC, Williams WM, Sweetman BJ, Smigel M, Nies AS, Carr K, Watson JT, Oates JA: Urinary prostaglandins: identification and origin. J Clin Invest 55:763–770, 1975 | PubMed | ISI | ChemPort |
  10. Erdös EG, Yang HYT: Kininase, in Handbook of Experimental Pharmacology: Bradykinin, Kallidin and Kallikrein, edited by Erdös EG, New York, Springer, 1970, Vol. 25, pp. 289–323
  11. Geller RG, Margolius HS, Pisano JJ, Keiser HR: Effects of mineralocorticoids, altered sodium intake and adrenalectomy on urinary kallikrein in rats. Circ Res 31:857–861, 1972
  12. Margolius HS, Chao J, Kaizu T: The effects of aldosterone and spironolactone on renal kallikrein. Clin Sci Mol Med 3(Suppl):279s–282s, 1976
  13. Mills IH, Macfarlane NAA, Ward PE, Obika LFD: The renal kallikrein-kinin system in the regulation of salt and water excretion. Fed Proc 35:181–188, 1976
  14. McGiff JC, Itskovitz HD, Terragno NA: The actions of bradykinin and eledoisin in the canine isolated kidney: Relationships to prostaglandins. Clin Sci Mol Med 49:125–131, 1975 | PubMed | ISI | ChemPort |
  15. Nasjletti A, McGiff JC, Colina-Chourio J: Interrelations of the renal kallikrein-kinin system and renal prostaglandins in the conscious rat: Influence of mineralocorticoids. Circ Res 43:799–807, 1979
  16. McGiff JC, Crowshaw K, Terragno NA, Lonigro AJ: Release of a prostaglandin-like substances into renal venous blood in response to angiotensin II. Circ Res 26–27 (Suppl. 1):I-121–I-130, 1970
  17. Larsson C, Weber P, Änggård E: Arachidonic acid increases and indomethacin decreases plasma renin activity in the rabbit. Eur J Pharmacol 28:391–394, 1974 | PubMed |
  18. Webster ME, Gilmore JP: Influence of kallidin-10 on renal function. Am J Physiol 206:714–718, 1964 | PubMed | ChemPort |
  19. Johnston HH, Herzog JP, Lauler DP: Effect of prostaglandin E! on renal hemodymtmics, sodium and water excretion. Am J Physiol 213:939–946, 1968
  20. Marin-Grez M, Cottone P, Carretero OA: Evidence for an involvement of kinins in regulation of sodium excretion. Am J Physiol 223:794–796, 1972 | ChemPort |
  21. Marin-Grez M, Oza NB, Carretero OA: The involvement of urinary kallikrein in the renal escape from the sodium retaining effect of mineralocorticoids. Henry Ford Hosp Med J 21:85–90, 1973
  22. Geller RG, Margolius HS, Pisano JJ, Keiser HR: Effects of mineralocorticoids, altered sodium intake and adrenalectomy on urinary kallikrein in rats. Circ Res 31:857–861, 1972
  23. Johnston CI, Matthews PG, Dax E: Renin-angiotensin and kallikrein-kinin systems in sodium homeostasis and hypertension in rats. Clin Sci Mol Med 51:283s–286s, 1976
  24. Margolius HS, Horwitz D, Geller RG, Alexander RW, Gill JR Jr, Pisano JJ, Keiser HR: Urinary kallikrein excretion in normal man: Relationships to sodium intake and sodium-retaining steroids. Circ Res 35:812–819, 1974
  25. Abe K, Yasujima M, Sakurai Y, Chiba S, Ito T, Imai Y, Sato M, Haruyama T, Omata K, Goto T, Sato K, Hiwatari M, Otsuka Y, Yoshinaga K: The role of renal prostaglandin E and kallikrein in pathogenesis of essential hypertension. Jap Cire J 43:1105–1116, 1979
  26. Tobian L, O'Donnell M: Renal prostaglandins in relation to sodium regulation and hypertension. Fed Proc 35:2388–2392, 1976
  27. Yasujima M, Abe K, Chiba S, Sato M, Irokawa N, Seino M, Imai Y, Saito K, Sakurai Y, Ito T, Haruyama T, Ritsu K, Yoshinaga K: Implication of renal prostaglandin E in urinary sodium excretion. Jap Circ J 42:565–569, 1978
  28. Carretero OA, Oza NB, Piwonska A, Ocholik T, Scicli AG: Measurement of urinary kallikrein activity by kinin radioimmunoassay. Biochem Pharmacol 25:2265–2270, 1976
  29. Abe K, Kato H, Sakurai Y, Itoh T, Saito K, Haruyama T, Otsuka Y, Yoshinaga K: Estimation of urinary kinino-genase activity using bovine serum low molecular weight kininogen, in Kinins-II: Biochemistry, Pathophysiology, and Clinical Aspects, edited by Fujii S, Moriya H, Suzuki T, New York, Plenum, 1979, Vol, A, pp. 105–114
  30. Abe K, Yasujima M, Chiba S, Irokawa N, Itoh T, Yoshinaga K, Saito T: Effects of furosemide on urinary excretion of prostaglandin E in normal volunteers and patients with essential hypertension. Prostaglandins 14:513–521, 1977
  31. Zusman RM: Quantitative conversion of PGA or PGE to PGB. Prostaglandins 1:167–168, 1972
  32. Jaffe BM, Behman HR, Parker LW: Radioimmunoassay measurement of prostaglandin E, A and F in human plasma. J Clin Invest 52:398–105, 1973 | PubMed | ChemPort |
  33. Ohki S, Hanyu T, Imaki K: Radioimmunoassays of prostaglandins F2alpha-main urinary metabolite with prostaglandin 125I-tyrosine methyl ester amide. Prostaglandins 6:137–148, 1974
  34. Abe K, Otsuka Y, Saito T, Chin BS, Aoyagi H, Miyazaki S, Irokawa N, Seino M, Yoshinaga K: Measurement of plasma renin activity by angiotensin I radioimmunoassay: A modification of Haber's method. Jap Cire J 36:741–749, 1972
  35. Haber E, Koerner T, Page LB, Purnode A: Application of a radioimmunoassay for angiotensin I to the physiologic measurement of plasma renin activity in normal human subjects. J Clin Endocrinol Metab 29:1349–1955, 1969 | PubMed | ISI | ChemPort |
  36. Williams GH, Cain JP, Dluhy RG, Underwood RH: Studies of the control of plasma aldosterone concentration in normal man: I. Response to posture, acute and chronic volume depletion, and sodium loading. J Clin Invest 51:1731–1742, 1972
  37. Katz FH, Romfh P, Smith JA: Episodic secretion of aldosterone in supine man: Relationship to Cortisol. J Clin Endocrinol Metab 35:178–181, 1972
  38. Bowden RE, Ware JH, DeMets DL, Keiser HR: Urinary excretion of immunoreactive prostaglandin E: a circadian rhythm and the effect of posture. Prostaglandins 14:151–161, 1977
  39. Vinci JM, Gill JR Jr, Bowden RE, Pisano JJ, Izzo JL Jr, Radfar N, Taylor AA, Zusman RM, Bartter FC, Keiser HR: The kallikrein-kinin system in Bartter's syndrome and its response to prostaglandin synthetase inhibition. J Clin Invest 61:1671–1682, 1978
  40. Patak RV, Mookerjee BK, Bentzel CJ, Hysert PE, Babeu M, Lee JB: Antagonism of the effects of furosemide by indomethacin in normal and hypertensive man. Prostaglandins 10:649–659, 1975
  41. Romero JC, Dunlap CL, Strong CG: The effects of indomethacin and other anti-inflammatory drugs on the renin-angiotensin system. J Clin Invest 58:282–290, 1976
  42. Tan SY, Mulrow PJ: Inhibition of the renin-aldosterone response to furosemide by indomethacin. J Clin Endocrinol Metab 45:174–176, 1977
  43. Weber PC, Schere B, Larsson C: Increase of free arachidonic acid by furosemide in man as the cause of prostaglandin and renin release. Eur J Pharmacol 41:329–332, 1977
  44. Gerber JG, Nies AS: Furosemide-induced renal vasodilation: The role of the release of arachidonic acid. Abst 4th Int Prostaglandin Conf, Washington, D.C., 1979, p. 40
  45. Paulsrud JR, Miller ON: Inhibition of 15-OH prostaglandin dephydrogenase by several diuretic drugs (abstr). Fed Proc 33:590, 1974

Extra navigation

.
ADVERTISEMENT